Patrick L. Reeson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Patrick L. Reeson has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Ana Paula Cota
Division of Medical Sciences, University of Victoria, Victoria, Canada
1 shared publication- Craig E. Brown
Division of Medical Sciences, University of Victoria, Victoria, Canada
1 shared publication - Jakob Körbelin
Department of Oncology, Hematology and Bone Marrow Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
1 shared publication Kamal Narayana
Division of Medical Sciences, University of Victoria, Victoria, Canada
1 shared publication- Lisa Anne Reynolds
Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada
1 shared publication Manjinder Cheema
Division of Medical Sciences, University of Victoria, Victoria, Canada
1 shared publication
Latest Publications
- Open Access
- 4 November 2024
- Published by Springer Nature in Nature Metabolism
- Vol. 6 (11) , 2082-2099
A pathogenic role for IL-10 signalling in capillary stalling and cognitive impairment in type 1 diabetes
Vascular pathology is associated with cognitive impairment in diseases such as type 1 diabetes; however, how capillary flow is affected and the underlying mechanisms remain elusive. Here we show that capillaries in the diabetic mouse brain in both sexes are prone to stalling, with blocks consisting primarily of erythrocytes in branches off ascending venules. Screening for circulating inflammatory cytokines revealed persistently high levels of interleukin-10 (IL-10) in diabetic mice. Contrary to expectation, stimulating IL-10 signalling increased capillary obstruction, whereas inhibiting IL-10 receptors with neutralizing antibodies or endothelial specific knockdown in diabetic mice reversed these impairments. Chronic treatment of diabetic mice with IL-10 receptor neutralizing antibodies improved cerebral blood flow, increased capillary flux and diameter, downregulated haemostasis and cell adhesion-related gene expression, and reversed cognitive deficits. These data suggest that IL-10 signalling has an unexpected pathogenic role in cerebral microcirculatory defects and cognitive impairment associated with type 1 diabetes.
- 4 November 2024
- Published by Springer Nature in Nature Metabolism
- Vol. 6 (11) , 2082-2099
Open AccessA pathogenic role for IL-10 signalling in capillary stalling and cognitive impairment in type 1 diabetes
Vascular pathology is associated with cognitive impairment in diseases such as type 1 diabetes; however, how capillary flow is affected and the underlying mechanisms remain elusive. Here we show that capillaries in the diabetic mouse brain in both sexes are prone to stalling, with blocks consisting primarily of erythrocytes in branches off ascending venules. Screening for circulating inflammatory cytokines revealed persistently high levels of interleukin-10 (IL-10) in diabetic mice. Contrary to expectation, stimulating IL-10 signalling increased capillary obstruction, whereas inhibiting IL-10 receptors with neutralizing antibodies or endothelial specific knockdown in diabetic mice reversed these impairments. Chronic treatment of diabetic mice with IL-10 receptor neutralizing antibodies improved cerebral blood flow, increased capillary flux and diameter, downregulated haemostasis and cell adhesion-related gene expression, and reversed cognitive deficits. These data suggest that IL-10 signalling has an unexpected pathogenic role in cerebral microcirculatory defects and cognitive impairment associated with type 1 diabetes.